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          Abstract 
 
Molecular Characterization of the ATPase component of a putative ABC  
type transporter in  Moraxella catarrhalis 
 
 
Moraxella catarrhalis is one of the major causes of respiratory tract and middle ear 
infections. Little is known about the pathogenesis of M. catarrhalis infection. A pathogenic 
bacterium requires adherence, invasion, establishment and dissemination with the host for a 
successful infection. The interaction between the host and the pathogen also includes uptake 
and secretion of substances that are facilitated by a family of proteins termed transporters. 
ATP-binding cassette (ABC) transporter is one of the active transport system common in 
prokaryotic and eukaryotic cells. In this study, we identified a gene encoding ATPase 
component of the ABC type transporter in M. catarrhalis and performed a nucleotide and 
deduced amino acid sequence analysis of this gene. We used Genomic Survey Sequence 
approach (GSS) to identify the gene from M. catarrhalis genomic library. The insert size of the 
positive clone is 934 bp and was sequenced by DNA walking. The ATPase domain of an ABC 
type transporter has conserved motifs: Walker A, Q loop, C loop (signature sequence), Walker 
B, D loop and Switch II. The ATPase domain is considered as the most conserved domain of 
the ABC type transporter due to presence of these motifs. Based on the homology and motif 
search, and amino acid sequence alignment, performed by using BLAST programs available on 
the internet, it was found that the deduced amino acid sequence encoded by this gene exhibited 
50-80% identity with the sequences of the ATPase component of the ABC transporters of 
several pathogens. 
 
 
Keywords: Moraxella  catarrhalis, ABC type transporter, ATP-binding cassette transporter, 
ATPase domain, Walker A, Walker B. 
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ÖZET 
Moraxella catarrhalis’te bulunan muhtemel bir ABC taşıyıcısının 
ATPase komponenti’nin Moleküler Karakterizasyonu 
 
Moraxella catarrhalis, solunum yolu enfeksiyonları ve orta kulak iltihaplarının en 
büyük etkenlerinden biridir. M. Catarrhalis’in hastalık yapıcı özelliği hakkındaki şu ana kadar 
edinilen bilgiler çok az.  
Patojenik bir bakterinin konakladığı canlıda enfeksiyona yol açabilmesi için, 
konakladığı canlının hücrelerinin yüzeyine  yapışması birinci koşuldur. Konak canlının 
hücrelerine yapışıp çoğalan patojen; ardından tüm vücuda yayılarak canlıda bir enfeksiyona 
sebep olabilir. Patojen ve konak canlı arasındaki etkileşimi sağlayan olaylardan bir tanesi de , 
iki canlı arasında, bazı protein taşıyıcıları (transporter) aracılığıyla, sağlanan alış verişdir. 
Bunlardan ATP-binding cassette (ABC) transporter sistemleri hem ökaryotlarda hem de 
prokaryotlarda aktif transportta yer alır. Bu tez çalışmasında,  M. Catarrhalis’de bulunan 
muhtemel bir ABC transporter’ın ATP componentinin moleküler karakterizasyonu yapılmıştır. 
Bu proteinin DNA ve amino asit dizileri çıkarılmıştır. Bu genin karakterizasyonunda yapılan 
deneylerde esas alınan yaklaşım Genomic Survey Sequence (GSS) approach’tur. Elimizdeki 
pozitif klonda bulunan insert, DNA walking methodu kullanılarak sekanslanmıştır. Buna göre 
ATPase komponentinin yapısında bulunan korunmuş motifler şunlardır: Walker A, Q loop, C 
loop (signature sequence), Walker B, D loop and Switch II. ATPase komponentinin ABC 
taşıyıcılarında en korunmuş yapı olarak kabul edilmesinin  sebebi yapısında bu motifleri 
barındırıyor olmasıdır. Amino asit dizisi, çokça kullanılan, güvenilir biyoinformatik 
programlarından biri olan BLAST veri tabanında taranmıştır. Buna göre klonumuza ait amino 
asit dizisi bu veri tabanında bulunan diğer patojen bakterilerdeki ATPase komponentleriyle % 
50-70 arası homoloji göstermiştir. Böylece, klonumuza ait amino asit dizisinin ABC 
taşıyıcılarıyla olan yakınlığı istatistiksel verilerle ortaya konmuştur.   
 
Anahtar Kelimeler: Moraxella catarrhalis, ABC protein taşıyıcısı, ATPase komponent, Walker 
A, Walker B. 
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Introduction 
 
ABC Type Transporters: 
 
Bacterial membrane transport occurs via pores, phosphoenolpyruvate (PEP)-dependent 
phosphotransferase (PTS) and peptide transporter systems such as ATP-binding cassette (ABC) 
type transporters. An ATP-binding cassette (ABC) type transporter is a protein having a 
characteristic ATPase domain, which is responsible for specific, unidirectional matter 
transportation across a lipid bilayer by ATP hydrolysis.  These ABC type transporters are 
among the most conserved and wide spread protein superfamily found in from microbe to man 
(Schmitt L 2000; Higgins CF 2001; Verdon G 1998;). For instance, nearly 5% of the 
Escherichia coli genome encodes components of ABC transporters (Linton KJ 1998; Higgins 
CF 2001; Verdon G 1998). 
The ABC type transporters are also called as traffic ATPases (Higgins CF 1992).  There 
are three reasons for this designation. First of all, the ATP-binding sites in all ABCs are very 
similar in amino acid sequence. This implies that the members of the family hydrolyze ATP 
during transport processes. Secondly, the family members can translocate a variety of 
substrates differs both in size and shape. Finally, the term traffic is used to state that the 
transport takes place in either direction (Doige CA 1993).   
Bacterial ABC transporters generally consists of up to four separate protein subunits, 
whereas their eukaryotic counterparts are generally composed of a single polypeptide (Locher 
KP 2002). Mainly the ABC type transporters are made up of four domains. Two of them are 
called as transmembrane domains (TMDs). They form a pathway across the membrane through 
which solutes move. These domains consist of multiple membrane spanning segments 
(putative a-helices) contain the substrate binding sites. On the other hand, the other two 
domains are highly conserved nucleotide –binding domains (NBDs), i.e. the ATPase domain. 
The NBDs are located at the cytoplasmic face of the membrane. They couple ATP hydrolysis 
and substrate translocation. (Schneider E 1998; Detmers F 2001; Locher KP 2002; Higgins CF 
2001). 
In general we can divide ABCs into three groups: Importers are mainly the prokaryotic 
substrate binding protein-dependent (BPD) transporters and they provide essential nutrients to 
bacteria even if these substances are present in submicromolar concentrations in the 
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environment. Exporters are found in both prokaryotes and eukaryotes. They are involved in the 
extrusion of waste products, the secretion of extracellular toxins and the targeting of membrane 
components. The third class of ABC systems are not involved in transport. However, they are 
involved in cellular processes such as DNA repair, translation or regulation of gene expression. 
(Schneider E 1998; Schmitt L 2002; Higgins CF 2001; Dassa E 2001; Locher KP 2002).  
The ABC type transporters have a wide variety of physiological functions, including 
import of essential nutrients in prokaryotes, export of waste products out of the cell in both 
prokaryotic and eukaryotic cells. Additionally, they are involved in a large variety of 
processes, including signal transduction, protein secretion, drug and antibiotic resistance, 
antigen presentation, bacterial pathogenesis and sporulation.  
The bacterial permeases are involved in solute uptake. They have been extensively 
analyzed and some shown to have homologous protein components with ATP-binding 
consensus sites (Fath MJ 1993). These permeases are members of an ABC superfamily, which 
includes the medically important eukaryotic multidrug resistance (MDR) protein and cystic 
fibrosis transmembrane regulator (CFTR) (Doige CA 1993). Members of this superfamily are 
very much alike in both sequence and structure; they have an ATP-binding motif (Doige CA 
1993; Locher KP 2002).  Moreover, in bacteria, multi-component permease consisting of one 
periplasmic substrate-binding protein, two hydrophobic cytoplasmic membrane protein with 
the ATP-binding motifs, forms a complex substrate binding protein-dependent transport 
system. This complex enables the bacteria to transport nutrients much more effectively 
(Schneider E 1998; Dassa E 2001; Mourez M 1997).  
On the other hand, all of the eukaryotic ABC type transporters have their ATP-binding 
domain on a single polypeptide with the TMDs. Several of these ABCs have significant 
medical importance and since their discovery they have been studied very much in details. 
Among these, the ABC transporter MDR1 is responsible for the resistance of tumor cells to 
chemotherapy, and mutations in the ABC transporter, CFTR is the main cause of the most 
frequently occurring deadly inherited disease, cystic fibrosis (Gottesman MM 2001; Schmitt L 
2000; Schmitt L 2002; Dassa E 2001; Verdon G 1998; Chang G 2001; Higgins CF 2001; 
Young J 1999). The Transporter associated with antigen processing protein (TAP) is another 
clinically important relevant ABC transporter, which is responsible for translocation of 
antigenic polypeptides from cytoplasm into endoplasmic reticulum (ER). In the ER they are 
being loaded onto major histocompatibility complex (MHC) class I molecules (Schmitt L 
2000; Detmers F 2001; Dassa E 2001; Locher KP 2002). 
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As mentioned above, the highly conserved motifs of ATPase domainATPase domain 
are the common feature of all members in the ABC superfamily. Many of these motifs, such as 
P-loop or Walker A motif; the Walker B motif, a glutamine residue in the Q loop, and a 
histidine residue in the Switch region, are directly involved in the binding and hydrolysis of 
ATP. In addition, ATPase domain has a D loop and a short polypeptide stretch (…LSGG…), 
which is so specific to this protein class that is generally called as “ABC signature sequence” 
(Gottesman MM 2001; Saurin W 1999; Doige CA, 1993; Locher KP 2002; Higgins CF 1992). 
 
Structure: 
 
The first high-resolution structure of an ATPase domain, HisP, the ATP-binding 
domain of histidine permease isolated from Salmonella typhimurium  
(Figure 1a), was reported in 1998 (Higgins CF 1982; Schmitt L 2002). The structure of HisP 
enables the scientists to understand the properties of ABC transporters and of defective CFTR 
proteins (Verdon G 1998). The HisP showed a novel, two-domain architecture. Domain I, the 
catalytic domain, has an α/β structure and contains the nucleotide-binding site, which is formed 
by a Walker A motif that precedes helix 1 plus the first three residues of this helix. In addition 
to this frequently encountered sequence (which is observed in many ATPases and GTPases), 
arm I contains the Walker B motif, is located in strand 9, and a conserved histidine, which acts 
as a γ-phosphate sensor, in the so-called ‘switch II’ region between strand 10 and helix 7. A 
sequence alignment of the ABC domains for which structures have been solved is shown in 
Figure 1b (Schmitt L 2002). 
A conserved glutamine-rich sequence (residues 154-162 in His P; bacterial consensus 
sequence LSGGQQQRV), called the ‘linker peptide, ‘signature motif’ or ‘ motif C, is located 
in arm II in the crystal structure, with part of it forming the first half of a-5 and with residues 
154-158 only being partially exposed. Several mutations of this motif inactivate the permease 
activity indicating that the motif performs an essential function. It is possible that the motif is 
necessary for the integrity of the folded HisP molecule (Verdon G 1998). 
 12 
 
 Fig.1) ATPase domain: structure-sequence conservation. (a) Structure of HisP. Helices are shown in red, 
strands are shown in blue and ATP is shown in ball-and-stick representation. (b) Sequence alignments of all 
reported X-ray structures of ATP-binding domains. Conserved motifs are colored and labeled. Secondary 
structure elements indicated above the alignment are from HisP (Schmitt L 2002). 
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Mechanism: 
 
It is generally assumed that all ATPase domains bind and hydrolyze ATP in a similar 
fashion and use a common mechanism to power the translocation of substrate through the 
membrane-spanning partner domains. According to the current view of the mechanism begins 
with binding of the substrate to the transporter. Importers in gram-negative bacteria generally 
require a periplasmic binding protein that delivers the substrate to the periplasmic side of the 
transporter, whereas exporters recruit their substrates directly from the cytoplasm or, in the 
case of hydrophobic substances, from the inner leaflet of the plasma membrane. The binding 
event is signaled to the nucleotide hydrolysis sites, where it is thought to increase the affinity 
for ATP, a prerequisite for a productive transport cycle. The two ATPase domains then carry 
out the “power stroke”, a highly cooperative ATP-binding and hydrolysis reaction that is 
concurrent with a substantial conformational change. This change is coupled to mechanistically 
critical rearrangements in the membrane-spanning domains associated with unidirectional 
substrate translocation, which is believed to occur through a tailored pathway at the domain 
interface. After the substrate has crossed the membrane, the transporter returns to the resting 
state through the dissociation of ADP and inorganic phosphate (Locher KP 2002). 
 
Moraxella catarrhalis: 
 
Moraxella (Branhamella) catarrhalis, formerly called Neisseria catarrhalis or 
Micrococcus catarrhalis is a gram-negative aerobic diplococcus that is frequently found as a 
normal inhabitant of human respiratory tract. This bacterium has emerged as a pathogen over 
the last 20 years,  (Johnson 1981). However, now it is considered as an important cause of 
respiratory tract infection (RTI) and otitis media together with Heamophilus influenzae and 
Streptococcus pneumoniae.    
M. catarrhalis had been known as a harmless commensal for a long time in this century. 
The reason for how or why suddenly emerged, as a pathogen is not yet known. However, the 
followings might be considered as major reasons: 
1. The bacterium may have changed such that it is now more virulent than in past decades. 
2. Since M. catarrhalis has long been regarded as a nonpathogenic commensal, infections 
by the organism may have been occurring but have been overlooked for years. 
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Since the infections M. catarrhalis causes results in a high level of morbidity and 
mortality and a substantial financial burden, It is important to explore this organism. For 
instance, it is responsible for about 15-20 % of all otitis media cases in children, in USA 
(Enright 1997). This results in a substantial financial burden ($2 billion/year in US) on the 
health care system (Murphy 1996). 
Although, it is accepted that M. catarrhalis is an established pathogen all over the 
world, its virulence factors remain to be discovered. Moreover, the pathogenesis of this 
bacterium is not yet clear, either. In addition, substantial increase in b-lactamase producing M. 
catarrhalis makes it difficult to treat with mostly used antibiotics (Martinez, 1998). Therefore, 
it is urgent to find new preventive and therapeutic strategies to fight with the infections caused 
by this bacterium. In addition to all these, the complete genome sequence of M. catarrhalis is 
not known.  
The outer membrane proteins (OMPs) of M. catarrhalis are similar to other gram-
negative bacteria. Similar to them 10 to 20 OMPs are present with 6 to 8 of these proteins 
predominating (Murphy 1990). The outer membrane of M. catarrhalis contains 8 major OMPs 
that are named beginning with OMP A to OMP H. The molecular weight of these proteins 
ranges from 98 to 21 kDa. It is interesting that there is a significant homogeneity among OMPs 
of 50 strains. This means that an immune response against one strain will also recognize a 
subsequent strain (Bartos 1988). 
 The list of the major OMPs of M. catarrhalis is given below: 
 
CopB: 
 One of the first OMP studied was CopB. It shows moderate degree of antigenic 
conservation when compared to other strains tested (Karalus 2000). Evidence for saying that an 
antigen is conserved:  
· Antibody reactivity 
· Restriction Fragment Length Polymorphism (RFLP) 
· Comparison of sequence of the gene 
 The protein is immunogenic as the antibody against it could be detected in convalescent 
sera of patients (Sethi 1995). Moreover, passive immunization of mice with the antibody 
against CopB resulted in enhanced clearance of M. catarrhalis from the lungs of these animals 
(Karalus 2000). Mutation and expression analysis show that CopB is involved in iron 
acquisition. Iron is an important element for many bacteria to live on their mammalian hosts. 
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Therefore bacteria developed strategies to transfer low concentration of iron from their 
environment.  
OMP CD: 
 Sequence analysis and RFLP studies on OMP CD show high degree of conservation 
among different strains of M. catarrhalis. It is a heat-modifiable protein that was initially 
reported as OMP C and OMP D. Then it was realized that these two bands were the two forms 
of a single antigen. BLAST search shows that the protein has homology with Pseudomonas 
aeruginosa porin protein (Murphy 1993). The antibody against OMP CD elicit complement-
mediated bactericidal activity against various strains of M. catarrhalis which indicate it may 
stimulate a protective immune response if used as a vaccine.   
 
UspA1 and UspA2: 
 They were first named as High Molecular Weight OMP (HMW-OMP) since the protein 
forms oligomeric complexes. Later on it was realized that the complex was composed of two 
proteins and named as ubiquitous surface protein A1 and A2 (UspA1 and UspA2). They were 
characterized as a single protein not only because of a single band in Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE ) but also because they share a common 
epitope. In fact they share a common 140-aminoacid region that is 93% identical (Cope 1999). 
In addition, passive immunization of mice with the antibody against CopB resulted in 
enhanced clearance from the lungs of these animals (Karalus 2000). 
 
Fimbriae: 
 Fimbriae have been described on the surface of M. catarrhalis by electron microscopy 
(Ahmed 1990). In M. catarrhalis, fimbriae are responsible for adherence and 
hemagglutination, therefore thought to be an important virulence factor (Ahmed 1992a).  It was 
also found that fimbriae are present on all fresh isolates of M. catarrhalis, and it decreases in 
number upon repeated in vitro passages (Ahmed 1992). Since fimbriae has not been isolated, 
little information available regarding the characterization of these structures. 
Lipooligosaccharide(LOS): 
Another prominent bacterial surface component of M. catarrhalis is the LOS. M. 
catarrhalis LOS shares homology with LOS of other gram-negative bacteria. In addition, these 
shared LOS epitopes have been implicated as a virulence factor for M. catarrhalis i.e. resistance 
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to bactericidal activity mediated by normal human serum (Zaleski 2000). There are three major 
LOS serotypes in M. catarrhalis: A, B and C. these structures encompass 95% all strains studied 
to date (Rahman 1996). Recently, it has been suggested that LOS may act as an adhesin of M. 
catarrhalis (Hu W-G 2001). 
As in all prokaryotes, ABC type transporters involve in many cellular transport 
processes in M. catarrhalis. In some cases they might be responsible for bacterial resistance to 
antibiotics. By using the genomic survey sequence approach (GSS) (Rosinha GM, 2002) in this 
project the ATPase domain of an ABC type transporter in M. catarrhalis was identified.  
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MATERIALS AND METHODS 
 
2.1 MATERIALS 
 
2.1.1 Chemicals 
 
All chemicals were of analytical grade and supplied by Sigma-Aldrich Chemie GmbH 
(Germany) except for: 
· Ampicillin was purchased from Roche Diagnostics GmbH (Germany). 
· IPTG and X-Gal were purchased from MBI Fermentas Inc. (USA). 
 
 
2.1.2 Bacterial Strains 
 
For all purposes M. catarrhalis B-88-152 isolated from sputum of patients with RTI 
and for cloning purposes E. coli DH5α were used. The E.coli strain was used in library 
construction and propagation of plasmids. The manufacturer is Bio-Rad (Hercules, USA). 
 
 
2.1.3 Enzymes 
 
The restriction enzyme HindIII, the DNA modifying enzyme, T4 ligase and 
Taq polymerase were purchased from MBI Fermentas Inc. (USA).  
 
 
2.1.4 Cloning vectors 
 
The pQE-31 (Qiagen Inc. USA) and pBluescript SK (Stratagene Inc. USA) vectors 
were used in colony hybridization experiments, as the pGEM T-Easy vector, Promega (USA) 
was used in cloning of PCR products. 
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Figure 2) The map of pBluescript cloning vector. It contains lacZ gene and suitable for α-
complementation. 
 
 
 
 
 
Figure 3) The map of pQE expression vector. It contains lac operon and is suitable for 
expression studies. 
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2.1.5 Commercially Available Kits 
 
· Qiaex II Gel Extraction Kit (by Qiagen Inc., USA) was used to purify PCR product from 
agarose gels.  
· MN Nucleospin Plasmid (Macherey-Nagel, GmbH& Co, Germany) was used in isolation 
of plasmids from E.coli. 
· DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosciences UK Limited, 
England) was used for sequencing reactions. 
 
2.1.6 Apparatus and Equipment 
 
Agarose gel electrophoresis were done by using horizontal mini gel apparatus Mupid-2 
purchased from Advance Co., Ltd., Japan. Thermal cycler for PCR was a product of Perkin 
Elmer (USA). 
 
 
Figure 4) pGEM®-T Easy Vector circle map. It contains lacZ gene and suitable for α-
complementation 
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2.1.7 DNA Size Marker 
 
1kb DNA ladder from MBI FERMENTAS Inc. (USA) was used as DNA size marker.  
  
2.2 SOLUTIONS AND MEDIA 
 
2.2.1  Agarose Gel Electrophoresis Solutions 
 
50X Tris-Acetic acid-EDTA (TAE)   Per Liter: 242 g Tris Base 
       57.1 ml Glacial Acetic acid 
       100 ml of 0.5 M EDTA 
 
Ethidium bromide  10 mg/ml in water (stock solution) 
       30 ng/ml (working solution) 
 
2.2.2 Microbiological Media and Antibiotics 
 
Luria-Bertani Medium (LB)    Per Liter: 10 g Bacto tryptone,  
                  5 g Yeast extract 
       5 g NaCl 
       15 g Agar (for solid media) 
  
Blood Agar                  %7 Rabbit blood in BHI agar 
 
Brain Heart Infusion (BHI) Agar   Per Liter: 52 g of BHI agar powder  
 
BHI Broth                         Per Liter: 37 g of BHI broth powder  
 
Mueller Hinton (MH) Broth                        Per Liter: 21 g of MHB powder 
    
 
Ampicillin                100 mg/ml (stock solution)  
100 μg/ml (working solution) in dH2O 
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2.2.3 Solutions for competent cell preparation: 
 
SOB medium (100ml)                   2% Bacto-tryptone 
(Sterilized by autoclaving)        0.5 % yeast extract 
   10 mM NaCl 
      2.5 mM KCl 
      10 mM MgCl2 
                     10 mM MgSO4 
      
Transformation Buffer (TB)                   10mM Pipes  
(Sterilized by filtration through        55mM MnCl2 
0.45μm filter, stored at 4 °C)                       15mMCaCl2     
                       250mM KCl     
          pH 6.7  
 
SOC                            SOB with 20mM glucose 
 
2.3 METHODS 
 
2.3.1 Growth and Maintenance of Bacteria 
 
2.3.1.1         M. catarrhalis 
 
The stocks of the M. catarrhalis strains were done in MH broth containing 5% rabbit 
blood and stored at -20C until use. Prior to stocking, the bacteria were cultured on 7% rabbit 
blood agar plates. Then, the colonies were taken with a sterile cotton swab and transferred into 
the 1 ml of media contained in a cryotube. During experiments, after cultured on BHI agar, the 
bacteria were incubated within a box containing 5% CO2 at 37 °C. The CO2 generated by the 
CO2 Gen Compact (Oxoid Limited, UK). All media were purchased from Merck Kga 
(Germany). 
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2.3.1.2  E. coli 
 
E. coli strains were stored in 50% sterile glycerol at -70 °C till it was used. The 
stocking was done as following: Overnight grown cultures were mixed with sterile glycerol in 
a ratio of 1:1, mixed for homogenization and kept at -70 °C. During the experiments the E. coli 
were cultured either on LB agar or in LB broth. The broth cultures were incubated in a rotary 
shaking incubator at 37 °C with a speed of ~200 rpm. Similarly, LB agar plates were incubated 
overnight at 37 °C incubator. 
  
2.3.2 DNA Experiments 
 
2.3.2.1    Competent Cell preparation and E. coli transformation 
 
2.3.2.1.1 Simple and Efficient Method (SEM) for Preparation  
                        of Competent Cells 
 
A single colony of appropriate E. coli DH5α strain was inoculated into 15 ml of LB 
broth (containing the appropriate antibiotics which is ampicillin in this study) and grown 
overnight at 37 °C. Then, the starter culture was diluted to OD600 of 0.2-0.3 into 250 ml of 
SOB medium and grown until the OD600 of the culture reaches to 0.6 at 18 °C with a speed of 
200-250 rpm shaking. It is very important that the aeration of the culture during growth is well. 
For this grow the culture into a wide flask closed with a sterile cotton cab. After that, the 
culture was chilled on ice for 10 minutes, and centrifuged at 2500 X g for 10 minutes at 4 °C. 
The pellet was resuspended in 80 ml of ice-cold TB, and an other 10 minute incubation on ice 
was done. The mixture was pelleted as mentioned above, resuspended gently in another 20 ml 
of TB. After that, DMSO was added to a final concentration of 7%, mixed gently and 
incubated on ice for 10 minutes for the last time. Subsequently, the aliquots of this mixture 
were done and these aliquots were chilled in liquid nitrogen, and then stored at -70 °C up to 3 
months without loss of transformation efficiency (Inoue et al. 1990). 
 
2.3.2.1.2  Transformation of E.coli  
  
An aliquot of frozen competent cells was thawed on ice. 200 μl of the cells was mixed 
with plasmid DNA with a concentration of less then 100 ng/μl in a 1.5 ml eppendorf tube and 
incubated on ice for 30 minutes. The cells were then exposed to 42 °C for a heat shock for 90 
seconds and chilled on ice for 2 minutes after the heat shock. 800 μl of SOC medium was 
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added and the cells were grown at 37 °C for 45 minutes with vigorous shaking at 250 rpm. The 
culture was then centrifuged and the pellet was resuspended in 100 μl of SOC, and spread on 
LB agar plates containing the appropriate antibiotic, which is ampicillin in this study.  
 
2.3.2.2         Plasmid DNA Isolation 
  
The plasmid, was isolated with MN Nucleospin Plasmid kit according to instructions of 
the manufacturer.  
 
2.3.2.3         DNA Ligation Reactions 
  
Ligation of the DNA fragments into plasmid vectors were done with 0.3-1.0 μg  
of linearized plasmid vector and 3-5 times molar excess of insert DNA in the presence  
of 1-4 Weiss units of T4 ligase and 1X concentration of the standard ligation buffer supplied by 
the T4 DNA ligase. And the mixture was incubated overnight at 16 °C.  
The reaction volume was 15ml. 
 
2.3.2.4          Restriction Enzyme Digestion 
 
In restriction enzyme digestion 5 μl of plasmid (1-10 μg/μl), 2 μl restriction enzyme 
buffer, and 1 μl restriction enzyme, HindIII, was mixed in small tubes and the reaction volume 
was adjusted to 20 μl with sterile ddH2O. 
 
2.3.2.5          Primers 
  
The primers for both sequencing and PCR reactions were designed by using the 
Primer3 program. The primers designed for PCR reactions were used in the sequencing 
reactions as well. The criteria for proper primer design are given below. 
· Tm (the melting temperature of the primer) in the range of 52 º C to 65 º C  
· Lack of dimerization capability  
· Lack significant hairpin formation (>3 bp)  
· Absence of secondary priming sites  
· Lower GC content as much as possible to avoid mispriming.  
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Generally the lengths of the primers used in this study were 19bp or 20 bp. Moreover, their GC 
content is ranging from 40 % to 55 %. All of the primers designed worked properly (Table 1 
and Table 2). All primers used in this study were custom synthesized and purchased  from 
Iontek (Bursa, Turkey). 
In addition, the primers designed for the first PCR reaction were constructed from the 
most conserved amino acid sequences of Walker A motif of several organisms, Neisseria 
meningitidis, Pseudomanas  aeruginosa, Haemophilus influenzae, Agrobacterium tumeficians, 
and Brucella melitensis, that insert B5 has significant homology. In addition to the most 
conserved amino acid sequence of the Walker A, gram negative codon usage was considered as 
ABC1 was designed; as the ABC2 primer was designed according to universal codon usage, 
and finally ABC3 was constructed by using universal codon usage, but in this case the primer 
has degeneracy (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
B5 2: 3’-TGGATGAGCTGCTTGATTTG-5’ 
 
ABC1: 5’-AACGGCAGCGGCAAAAGCAC-3’   
 
ABC2: 5’-TGGCCTAGTGGTAGTGGTA-3’        
 
ABC3: 5’-GGYCCYAGYGGYAGYGGYA-3’     
 
 
Table 2) Primers used in PCR assays 
 
 
KA2: 5’-TGCAGGTCTTGAAAATGCAG-3’ 
B5 2: 3’-TGGATGAGCTGCTTGATTTG-5’ 
 
T3: 5’-AATTAACCCTCACTAAAGGGA-3’  
 
T7: 5’ TAATACGACTCACTATAGGG 3’ 
 
 
Table 1) Primers used in sequencing reactions 
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2.3.2.6  Polymerase Chain Reaction (PCR) 
 
PCR was done in order to find out the Walker A motif in the putative ATPase domain 
of ABC transporter in M. catarrahalis. The reaction conditions and procedure for PCR are 
given below. In general all of the reagents were delivered in a 1.5 ml eppendorf tube and a 
master mix was prepared on ice. In addition, before and after giving the Taq polymerase, the 
master mix was mixed gently by vortexing.  
The master mix was distributed into PCR tubes with a volume of 48 µl. Then, 2 µl of 
M. catarrahalis genome template DNA was given into tubes. For negative control instead of 
genomic DNA, 2 µl sterile ddH2O was added. The PCR products were run on 0.8 % or 1.0 % 
agarose gel containing EtBr for visualization under UV lamp. 
 
2.3.2.6.1 PCR assay 
 
Three sets of PCR assays were done with three different forward primers (ABC1, 
ABC2 and ABC3), one for each set, and one reverse primer (B5-2), for all sets. The reaction 
volume in each PCR tube was 50 µl and the reaction cycle was 35. 
   
 
 
Reagents 
 
Final concentration 
 
 
Quantity for 50 µl 
of reaction mixture 
ddH2O - 33.1 µl 
10X PCR buffer 1X 5 µl 
25 mM MgCl2 1.75 mM 2.5 µl 
2 mM dNTP mix  0.2 mM of each 5 µl 
Primer I (B5-2)  20 pmol/µl 1 µl 
Primer II  (ABC1/ABC2 
/ABC3) 
20 pmol/µl 1 µl 
Taq DNA polymerase 1.25 u/50 µl 0.4 µl 
Template DNA 50 ng 2 µl 
Table 3) PCR assay mixture set up 
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2.3.2.7  Genomic DNA Isolation from M. catarrhalis 
 
 
Amplification steps 
 
 
Temperature  (ºC) 
 
Duration (min) 
Initial denaturation  94  5 
Denaturation  94 0:30 
Primer annealing  56 0:20 
Extending  72 1:10 
Final extending  72 5 
Table 4) The PCR conditions for amplification 
  
 
Large scale genomic DNA isolation was performed by the standard methods of Current 
Protocols for gram-negative bacteria. 100 ml BHI broth was inoculated with 1 or 2 colonies of 
M. catarrhalis. After overnight incubation the bacteria were harvested by centrifugation at 
10000 rpm. The pellet was resuspended in 8.75 ml of 10X TE (100mM Tris-HCl, pH 7.5, 10 
mM EDTA) by repeated pipetting and then transferred to a disposable 50 ml centritube. The 
cell suspension was frozen at -20 °C for 60 minutes. 1.0 ml of freshly prepared lysozyme (10 
mg/ml in 0.25 Tris-HCl, pH 8.0) solution was added to the frozen cells and then thawed by 
mixing in a room-temperature water bath. Just after thawing, the cells were put on ice for 45 
minutes. 0.25 ml of 20 % SDS, 50µl of 20mg/ml proteinase K and 10 µl of 10 mg/ml DNase-
free RNase was added to the cell suspension. After mixing thoroughly the solution was 
incubated at 55 °C for 1 hour with occasional gentle mixing. Then 1.8 ml of 5 M NaCl was 
added and the tube was mixed thoroughly by inverting for 5 minutes. 1.5 ml of CTAB/NaCl 
solution was added and the tube was mixed thoroughly and then it was incubated at 65 C for 20 
minutes with occasional shaking. 
 Approximately equal volumes of chloroform: isoamyl alcohol (49:1) was added, 
the tube was mixed thoroughly by inverting the tube for 5 minutes, and it was spin down 10 
min at 3000 rpm. The chloroform phase was removed and the supernatant and the interphase 
were homogenized with a plastic pipette. The suspension was centrifuged 10 min at 3000 rpm 
again and the aqueous, viscous supernatant was transferred to a fresh centrifuge tube, leaving 
the interface behind. An equal volume of phenol:chloroform: isoamyl alcohol (25:24:1), was 
added and the solution was extracted thoroughly by inverting the tube and was centrifuged 10 
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minutes at 3000 rpm. The aqueous, viscous supernatant was transferred to a fresh centritube, 
leaving the interface behind. 0.6 volume of isopropanol was added to precipitate the nucleic 
acids. The DNA pellet was transferred to a fresh tube containing 70 % ethanol by hooking it 
onto the end of a glass Pasteur pipette. The DNA was washed with 70 % ethanol to remove the 
residual CTAB and recentrifuged to pellet it. The supernatant was removed carefully and the 
pellet was dissolved in TE.  
 
2.3.2.8  Phenol-Chloroform Extraction 
 
Phenol-chloroform extraction was done to purify DNA after each enzymatic 
manipulation. First, an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) was 
added to the DNA solution containing the impurities. The optimum starting volume was about 
100 μl. If the solution was less than this volume it was diluted with ddH2O accordingly. After 
mixing 45 seconds by vortexing, the tube was centrifuged for 5 minutes at 13000 rpm. The 
upper (water phase) was transferred to a new eppendorf tube. Then 1/10 volume of 3M NaOAc 
was added.  After mixing by inverting the tube 2.5 volume of cold absolute ethanol was added. 
After mixing by inverting the tube was kept in -80C for 20 minutes. Then the tube was 
centrifuged for 10 minutes at 13000 rpm. After discarding the supernatant, the pellet was 
washed with 200 μl of 70% ethanol. After drying all the ethanol the pellet was dissolved in TE 
or water.  
 
2.3.2.9  Agarose Gel Electrophoresis 
 
DNA fragments of less than 1kb were generally separated on 1.0 % agarose gel, those 
greater than 1kb were separated on 0.8 % gels. Required amount of agarose gels were 
completely dissolved in 1X TAE buffer by heating in microwave, then ethidium bromide was 
added to a final concentration of 30 ng/ml. The DNA samples were mixed with one volume 
loading buffer and loaded onto gels. The gel was run at room temperature in 1X TAE at 50 V or 
100 V. 
 
2.3.2.10 Isolation of PCR Product from Agarose Gels 
 
The kit given in materials part was used in isolation of PCR product. We followed the 
instructions of the manufacturer.  
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 2.3.2.11 DNA Sequence Analysis  
  
 DNA sequence analysis of the positive clones was performed by the dideoxy chain 
termination method. Cycle sequencing reactions were set up in 0.2 ml eppendorf tubes. The 
sequencing procedure was performed by DYEnamic ET Terminator Cycle Sequencing Kit 
according to the instructions of the manufacturer. The cycle sequenase reactions were 
performed in Perkin Elmer GeneAmp PCR 9600 system thermal cycler with the following 
parameters: 25 cycles of denaturation (95 °C for 20 seconds), annealing (50 °C for 15 seconds) 
and extension (60 °C for 1 minutes). Electrophoresis was performed on the ABI PRISMTM 377 
Genetic Analyzer (Perkin Elmer, USA) by loading the samples into the lanes of a vertical 
polyacrylamide slab gel. The separated DNA fragments were exposed to a laser which in turn 
would excite the flourescent dyes attached to the fragments. These data were then collected and 
analyzed by the help of ABI Sequencing Analysis Software (version 3.0.1). 
 In addition, for complete nucleotide sequencing new primers were designed and the 
procedure mentioned above was used in subsequent sequencing reactions.  
 
 
Sample 
 
Template 
(500ng) (µl) 
 
Primer 
name 
 
Primer  
(2pmol/µl) (µl) 
 
Mix (µl) 
 
ddH2O (µl) 
B5 8 T3 2 8 2 
B5 8 T7 2 8 2 
B5 8 KA2 2 8 2 
B5 8 B52 2 8 2 
Control 1 Control 2 8 7 
Table 5) Protocol for DYEnamic ET Terminator Cycle Sequencing Kit 
 
2.3.2.12 Bioinformatic tools used for nucleotide and amino  
acid sequence analysis     
           
For nucleotide sequence homology search “BLAST align two sequences” tool was 
used. For conserved domain homology search, “the conserved domain homology search” 
engine of BLAST was used. In addition, translation of the inserts’ nucleotide sequences into 6 
phase amino acid sequence were done by the “justbio translator” tool and the complementary 
sequence of the inserts’ reverse sequences were obtained by using “justbio complementor 
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program”. Also, “justbio aligner” tool was used for two amino acid sequences alignments. 
Finally, for multiple amino acid sequence alignments “clustalW” program was used.  
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RESULTS 
 
 
3.1                 Isolation of the clones 
In previous studies performed in our lab, a genomic library of M. catarrhalis was 
prepared in pBluescript SK (pBSK) and pQE 31 vectors after digesting the genomic DNA with 
HindIII using standard molecular biology methods. Then transformation of the genomic library 
was done in E. coli DH5-α strain. The library constructed by using the pQE 31 vector was 
screened by monoclonal antibody (mAb) against 55kDa protein, which is an adhesin protein, 
isolated from M. catarrhalis in our lab. In addition, the library constructed  by using the pBSK 
vector was screened by an oligonucleotide probe deduced from N-terminal amino acid 
sequence of 55kDa protein.  
A total of 12 positive clones (B5, C1, 1B1, 1B2, 1B3, 3A, 3B, 5A, 6A, 8A, 8B1 and 8B2) out 
of 4000 colonies were identified based on X-gal detection method. The size of the inserts of the 
clones ranged from 750bp to 1500bp (Turan T 2002).  
 
3.2                  Nucleotide sequence 
 
We attempted to obtain the nucleotide sequence of the inserts of all of the clones (Table 
6). Inserts of clones, B5, C1 and 8B2 were sequenced completely. On the other hand, we 
obtained the partial sequences of the inserts of the rest of the clones. Almost 70 % to 80 % of 
these inserts were sequenced. Among these clones the insert of the B5 showed significant 
homology with the ATPase domain of the ABC type transporter.  
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Name of the clone Sequenced length of the insert  
pQE 31 clones 
1B1 1719bp 
1B2 929bp 
1B3 1135bp 
3A 1200bp 
3B 838bp 
5A 745bp 
6A 1063bp 
8A 1283bp 
8B1 902bp 
8B2 734bp (complete sequence of the insert) 
pBluescript SK+ clones 
B5 934bp (complete sequence of the insert) 
C1 1827bp (complete sequence of the insert) 
Table 6) The names of different clones and lengths of the completed sequences of the 
inserts. 
 
 
3.3        Amino acid sequence  
 
 
LHYLP*LLWSLKD**AIKNSTDDILVK*DLHQNLHIFINLSKQLSSMSIKHEY*N 
PKHP*NFRGFCCLR*NQH*YFNR*ADNFIRSIRLWQDNFATHYCRS[KCRQRA 
GYILTVSNVTDIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSA 
NTIDRRVDELLDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDE 
PFGALDAKVRKSLRDSLKDIQREIGITSILVTHDQEEAQAISDKIVIMNHGQIEQ 
IGTPSKLFAQPSSDFVVDFLGL]AMSHRSKINRHMVFNLH*SQX 
 
Table 7) The converted amino acid sequence of the insert of clone B5. The motifs of 
ATPase domain are found in the region shown dark within the brackets []. “ * ” Indicates 
the stop codons.  
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3.3.1  
         The conserved domain homology search was done in BLAST by using “conserved  
domain homology” search tool in BLAST. The second phase amino acid sequence of the 
insert B5 showed 50 % to 70 % homology with the ATP-binding domain, the ATPase of 
the ABC transporters of several bacterial species including, N. meningitides, P. 
aeruginosa, H. influenzae, H. pylori and S.  typhimurium  LT.  Figures 8 and 9 below 
show where 55% homology and 68% homology were found respectively. In both of the 
tables the query sequence is the insert B5 and the subject sequence is the corresponding 
consensus sequence. In addition, the CD-length shows the conserved domain length, bit 
score that each alignment has is the measure between the hit, the sequences that produce 
“significant” alignments to the query sequence, and the query. The Expectation value (e-
value) is "an assessment of the statistical significance of the score”. Also, the e-value is 
showing how random a match is or how much chance is involved. As a result, a low e-
value is an indication of a high homology. 
 
             CD-Length = 248 residues, only  55.2% aligned 
             Score =  136 bits (345), Expect = 1e-33 
 
 
 Query:  22   HRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSANTIDRRVDELLDLVQLSHTKTR  81 
 Sbjct:  71   GPDIGYVFQEDALLPWLTVLDNVALGLEL----RGKSKAEARERAKELLELVGLAGFEDK  126 
 
 Query:  82   YPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLKDIQREIGITSIL  141 
 Sbjct:  127  YPHQLSGGMRQRVAIARALATRPKLLLLDEPFGALDALTREELQDELLRLWEETRKTVLL  186 
 
 Query:  142  VTHDQEEAQAISDKIVIMNHG  162 
 Sbjct:  187  VTHDVDEAVYLADRVVVLSNR  207 
 
Figure 5) Homology between the insert B5 amino acid sequence (the query) and the 
consensus amino acid sequence (subject). For a detailed explanation please see the 
text above. 
 
 
 
             CD-Length = 217 residues, only  68.7% aligned 
             Score =  119 bits (299), Expect = 2e-28 
 
Query:  17   DIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSANTIDRRVDELLDLVQLS  76 
Sbjct:  69   DLRELRRRIGYVFQEPVLLFNGTVRENIAFGL----ELHGLSKEETRERVEEALELVGLH  124 
 
Query:  77   -HTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLKDIQREI  135 
Sbjct:  125  PDLLDRPPGQLSGGQRQRVAIARALLRDPKILLLDEPTSALDVESEAQILELLRELQEK-  183 
 
Query:  136  GITSILVTHDQEEAQAISDKIVIMNHGQIEQIGTP  170 
Sbjct:  184  GRTVLVVTHD-ELATRLADRILVLKNGKIVEQGTP  217 
 
Figure 6) Homology between the insert B5 amino acid sequence (the query) and 
the consensus amino acid sequence (subject). For a detailed explanation please see 
the text above. 
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3.3.1.1 
             Specific examples showing the most homologous amino acid sequences  
 between the ATPase components of insert B5 amino acid sequence and several     
 bacterial species: P.  aeruginosa, H.  influenzae, S.  aureus subsp. aureus N315,  
 N.  meningitidis serogroup B strain MC58, H.  pylori . In each figure, asterisks  
 indicate identical residues, colons indicate conserved substitutions, and periods  
 indicate semiconserved substitutions. In addition, the amino acids highlighted with 
orange indicates the regions those are most identical between the two sequences.  
 
 
CLUSTAL W (1.8) multiple sequence alignment 
  
  
 sequence1       MNAASRQPSTLPADALLAVDGVSLEYRTRSRVVRATQRVSFEVDPADRFVLLGPSGCGKS 
 sequence2       ---------------------------------KCRQRAGYILTVSN------------- 
                                                  :. **..: :  ::              
  
 sequence1       TLLKAVAGFITPSEGEIRLQGQAVRAPGPDRIVVFQEFDQLPPWKTVRQNVLFPLRVSGQ 
 sequence2       -----------VTDIPVQHRG----IG-----FVFQQYALFR-HQTVAQNIAFGLTLLPR 
                             ::  :: :*           .***::  :   :** **: * * :  : 
  
 sequence1       VTR---DEAERRADECLEKVGLAGFAEAYPHTLSGGMKARVAIARALAMQPKILLMDEPF 
 sequence2       NTRPSANTIDRRVDELLDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPF 
                  **   :  :**.** *: * *:     *** **** : ***:***** :**:**:**** 
  
 sequence1       AALDALTRRKMQEELLRLWEEVRFTLLFVTHSIEEALVVGNRILLLSPHPGRVRAEVHGH 
 sequence2       GALDAKVRKSLRDSLKDIQREIGITSILVTHDQEEAQAISDKIVIMN-HG---QIEQIGT 
                 .**** .*:.:::.*  : .*: :* ::***. *** .:.::*:::. *    : *  *  
  
 sequence1       PFGLHSLGGEPLQAAARRIHRLLFDEGGEPTAAATLDFADIRLAH 
 sequence2       PSKLFAQ----------------------PSSDFVVDFLGL---- 
             *  *.:                       *::  .:** .:     
 
Figure 7) Seq 1: P.  aeruginosa, Seq 2: Insert B5 
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CLUSTAL W (1.8) multiple sequence alignment 
  
  
 sequence1       MVRIQDLSLAFNGQTLFEHLNLTLLPNEWVSLLGSSGVGKSTLLRLLAGIETQGMVQGKI 
 sequence2       -------KCRQRAGYILTVSNVTDIP-----VQHR-GIG--FVFQQYALFRHQTVAQN-I 
                        .   ..  ::   *:* :*     :    *:*   :::  * :. * :.*. * 
  
   sequence1       LFEPKVRIAWLPQKETLYPWLSIVDNVQLQAVLFGRKSVKTTEKAKMLLEKVGMAAHWHK 
 sequence2       AFG----LTLLP-R----------N-TRPSANTIDRR-------VDELLDLVQLSHTKTR 
                  *     :: ** :          : .: .*  :.*:       .. **: * ::    : 
  
 sequence1       PCSQLSGGQKQRVALARTLMQEVDLILLDEPFSALDAISRHQLQDLAFELLEDK--SVLL 
 sequence2       YPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLKDIQREIGITSIL 
                    :*****:*******:*  * .*:******.****  *:.*:*   :: .:   : :* 
  
 sequence1       VTHDPQEALRLSQRIFVLRSPETHQTALSAVILPEGNAPRELHQANLWTLQQQLLQELGG 
 sequence2       VTHDQEEAQAISDKIVIMNHGQIEQIGTPSKLFAQ---PSSDFVVDFLGL---------- 
                 **** :**  :*::*.::.  : .* . .: ::.:   * . . .::  *           
  
 
Figure 8) Seq 1: H.  influenzae, Seq 2: Insert B5 
CLUSTAL W (1.8) multiple sequence alignment 
  
  
 sequence1       MIKIQQLQHHFGSHKVIHNFNLDISKGEIVTFIGKSGCGKSTLLNVIGGFIHPSSGRVII 
 sequence2       ------------KCRQRAGYILTVSN---VTDIPVQHRGIGFVFQQYALFRHQTVAQNIA 
                             . :   .: * :*:   ** *  .  * . :::  . * * : .: *  
  
 sequence1       DNEIKQQPSPDCLMLFQHHNLLPWKTINDNIRIGFQQKISDEEINAQLKLVDLEDRGKHF 
 sequence2       FG-----------LT-----LLPRNTRPS-------ANTIDRRVDELLDLVQLSHTKTRY 
                  .           :      *** :*  .        :  *..::  *.**:*..  .:: 
  
 sequence1       PEQLSGGMKQRVALCRAHVHKPNVILMDEPLGALDAFTRYKLQDQLVQLKHKTQSTIILV 
 sequence2       PHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLKDIQREIGITSILV 
                 *.:**** :*****.** . :*:::*:***:***** .* .*:*.* :::::   * *** 
  
 sequence1       THDIDEAIYLSDRIVLLGEGCNIISQYEITASHPRSRNDSHLLKIRNEIMETFALNHHQV 
 sequence2       THDQEEAQAISDKIVIMNHG-----QIEQIGTPS---------KLFAQPSSDFVVDFLGL 
                 *** :**  :**:**::..*     * *  .: .         *:  :  . *.::.  : 
  
 sequence1       EPEYYL 
 sequence2       ------ 
Figure 9) Seq 1: S.  aureus subsp. aureus N315, Seq 2: Insert B5 
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3.3.2     Motif search results 
 
CLUSTAL W (1.8) multiple sequence alignment 
  
  
 sequence1       MSITIQNLNKHFGNFHALKNINLNVPTGKLVSLLGPSGCGKTTLLRIIAGLENADGGNIL 
 sequence2       -------------------------------------KC-RQR------------AGYIL 
                                                       * :              .* ** 
  
 sequence1       FDGQDVTAKHVRERKVGFVFQHYALFRHMNVFDNVAFGLTVLPKSERPSKGQIRAKVEEL 
 sequence2       TVS-NVTDIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSANTIDRRVDEL 
                   . :**   *:.* :*****:****** .* :*:*****:**:. *** . *  :*:** 
  
 sequence1       LKLVQLSHLAKSYPHQLSGGQRQRIALARALAVEPKLLLLDEPFGALDAKVRKELRTWLR 
 sequence2       LDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLK 
                 *.******  . ***:********:*******.********************.**  *: 
  
 sequence1       DIHHNLGVTSILVTHDQEEALEVSDEIVVMNHGKIEQTGSAEAIYRKPENAFVTEFLGET 
 sequence2       DIQREIGITSILVTHDQEEAQAISDKIVIMNHGQIEQIGTPSKLFAQPSSDFVVDFLGL- 
                 **::::*:************  :**:**:****:*** *:.. :: :*.. **.:***   
  
 sequence1       DAFEGRIEKGFWHYNGFAWKLDAQYKWQEQTATGYIRPHEWQIAAEHETPMICAEIEKIH 
 sequence2       ------------------------------------------------------------ 
                                                                              
  
 sequence1       AVGALTHILVKHDKQDVHITLAGSDAARYPIAEGKELKLIPKQVYVFSQNELIEYSI 
 sequence2       --------------------------------------------------------- 
Figure 10) Seq 1: N.  meningitidis serogroup B strain MC58, Seq 2: Insert B5 
CLUSTAL W (1.8) multiple sequence alignment 
  
  
 sequence1       MKEIVTIENVSFNYHNRAVFKDFNLSIQEGDFLCVLGESGSGKSTLLGLILGLLKPSLGS 
 sequence2       -----------------------KCRQRAGYILTVSN----------------------- 
                                        :   : * :* * .                        
  
 sequence1       VKIFNETLSNNAFLRQKIGYIAQGNSLFSHLNAMQNMTFCLNLQGINKQAAQKEAK---A 
 sequence2       -------VTDIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSANTIDRRVD 
                        ::: .. :: **:: *  :** * .. **::* *.*   *.:.: :  .     
  
 sequence1       LALKMGLDESLMDKFPNELSGGQAQRVGIIRGIIHRPELILLDEPFSALDSFNRKNLQDL 
 sequence2       ELLDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDS 
                   *.:   .    ::*:****** ***.: *.:  .*:*:******.***:  **.*:*  
  
 sequence1       IKEIHQNSHATFIMVTHDESEAQKLATKTLEIKALKQEQ--------------------- 
 sequence2       LKDIQREIGITSILVTHDQEEAQAISDKIVIMNHGQIEQIGTPSKLFAQPSSDFVVDFLG 
                 :*:*:::   * *:****:.*** :: * : ::  : **                      
  
 sequence1       - 
 sequence2       L 
Figure 11) seq 1: H.  pylori, seq 2: insert B5 
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The ATPase domain motifs found in insert B5 amino acid sequence (Figure 12). The 
similarity of them with the motifs of most known, studied ATPase domains, HisP, MJ0796, 
Malk  (Figure13) (Schmitt L 2002). 
 
KCRQRAGYILTVSNVTDIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSANTIDRRVDEL 
         Q loop 
 
LDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKVRKSLRDSLKDIQREIGI 
   C loop      Walker B D loop  
 
TSILVTHDQEEAQAISDKIVIMNHGQIEQIGTPSKLFAQPSSDFVVDFLGL 
Switch II 
 
Figure 12) ATPase domain motif analysis of insert B5.  
 
  
 sequence1       KCRQRAGYILTVSNVTDIPVQHRGIGFVFQQYALFRHQTVAQNIAFGLTLLPRNTRPSAN 
 sequence2       ----------------------------FQHFNLWSH----------------------- 
                                             **:: *: *(HisP)                      
                                              Q loop 
  
 sequence1       TIDRRVDELLDLVQLSHTKTRYPHELSGGQRQRVALARALATEPKLLLLDEPFGALDAKV 
 sequence2       -------------------------LSGGQQQ-------------VLLFD---GALD---- 
                                          *****:*(HisP)       :**:*   ****                    
            (HisP) (MJ0796) 
                                           C loop           Walker B  D loop 
                            
 sequence1       RKSLRDSLKDIQREIGITSILVTHDQEEAQAISDKIVIMNHGQIEQIGTPSKLFAQPSSD 
 sequence2       -----------------TTIYVTHD----------------------------------- 
                                  *:* **** (Malk)                                            
                                   Switch II 
                                   
 sequence1       FVVDFLGL 
 sequence2       -------- 
 
Figure 13) Alignment between the motifs found in insert B5 and common ATPase 
domains, HisP, MJ0796, Malk.  
3.4 PCR results 
  To get the Walker A motif in the PCR product we did, the expected band range was 700 
bp to 1300 bp. After optimization of the PCR done we obtained two separate bands ranging from 
~780bp (the lower band) to ~1200bp (the upper band) from the PCR assay prepared by using 
ABC1 and B5-2 primers (Figure14). These PCR products were cloned in pGEM®-T Easy vector 
and sequenced. The results of sequencing reactions did not give a significant homology with any 
motif in ATPase domain of ABC transporter.  
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~1200bp
 ~780bp 
 
Figure14) PCR assay, forward 
primer is ABC1. The bands 
obtained after optimization of 
the PCR assay. 
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DISCUSSION 
 
 
In this study we attempted to sequence the inserts of different clones of  
M. catarrrhalis with the intention of identification of some genes in this organism.  
One of these, clone B5, has significant homology with the ATPase domain of ABC type 
transporters.  
The ATPase domain of an ABC type transporter has conserved motifs: Walker A, Q 
loop, C loop (signature sequence), Walker B, D loop and Switch II. The ATPase domain is 
considered as the most conserved domain of the ABC type transporter due to presence of these 
motifs. The insert B5 has all these except the Walker A motif. Therefore, we speculated that 
the insert B5 is an ATPase component of a particular ABC type transporter in M. catarrhalis.  
However, the function of this putative ABC type transporter of M. catarrhalis is not known. 
The specificity of ABC type transporter comes from its TMDs not from the NBDs (Schmitt L 
2002; Lage H 2003).  
In microorganisms, the ABC type transporters are involved in both import and export 
processes (Dassa E 2001). Also, they are responsible for drug resistance in many bacterial 
species. For example, ABC type transporters mediate antibiotic resistance of some human 
pathogens, such as S. aureus and Staphylococcus epidermidis. The inhibition of ABC type 
transporter function in these organisms has been a subject of intensive study (Lage H 2003). 
However, the ABC type transporters, which insert B5 has significant homology with, are 
generally ion transporters. As a result of this, the putative ABC type transporter of M. 
catarrhalis is not responsible for antibiotic resistance, but most probably is responsible for ion 
transport. In addition, M. catarrhalis is a b-lactamase producer. Since it has such an effective 
antibiotic resistance mechanism, the probability of having ABC type transporters responsible 
for drug resistance is very low. In summary, we proposed that the putative ABC type 
transporter, partially sequenced in this study, is an ion transporter, important for the survival of 
M. catarrhalis. The functional studies of this putative ABC type transporter will be performed 
after the full sequence of the ATPase domain is completed. 
In the insert B5 amino acid sequence there were some stop codons. Actually the 
presence of these stop codons was an unexpected situation.  Generally the stop codons, UAA, 
UAG, UGA, in universal genetic code may not be stop codons in bacterial genome. For 
example, Tetrahymena uses only one stop codon, UGA, to terminate protein synthesis. The 
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other stop codons, UAA and UAG are decoded as the glutamine codon (Nakamura Y 1998). In 
M.catarrhalis the stop codon identified so far, is UAA (Du R-P 1998; Kakuda T 2003). 
However, based on our literature search, which amino acid(s) was coded from the other stop 
codons, UAA and UAG, in M.catarrhalis has not been found yet. Since the nucleotide 
sequence of insert B5 was translated into its amino acid sequence by a program, which is using 
universal genetic code, the program might give false stop signals. Another explanation for the 
extra stop codons in the amino acid sequence of insert B5 could be the following. During clone 
selection two different fragments from the M. catarrhalis genomic DNA library might have 
come together and inserted into the same vector. If this is the case for clone B5, the stop 
codons coming before the amino acid sequence consisting of the motifs might belong to the 
fragment that did not include the ATPase domain. In addition, although we have confirmed the 
nucleotide sequence of insert B5 by doing the sequencing reaction two times, the polymerase 
might not work properly and some parts of the sequence could include false bases. 
Since the complete sequence of the ATPase domain is not known and the promoter 
sequence should be found before Walker A motif, the promoter sequence search will be 
performed after the full sequence of the ATPase component of the putative ABC type 
transporter in M. catarrhalis is completed. 
In the insert B5, the length of the ATP-binding cassette domain is 188 amino acids. Our 
literature search showed that in several bacteria, length of the NBD domain of the ABC 
transporters is about 215 amino acids (Linton KJ 1998). Therefore, it is necessary to find ~ 27 
amino acids to obtain the complete sequence of the ATP-binding domain of the putative ABC 
transporter of M. catarrhalis.  
The Walker A is the only motif that was remained to be identified. Since M. catarrhalis 
genome has not been fully sequenced yet, it was not possible to design a specific primer for this. 
Therefore, we followed another way to complete the putative ATPase domain. The primers were 
designed from the most conserved amino acid sequence of the Walker A motif of several species, N. 
meningitidis, P. aeruginosa, H. influenzae, A. tumeficians, and B. melitensis. Since the Walker A 
motifs of different species may show slight variations in some amino acids in the protein sequence 
(Holland IB 1999), in construction of the primers we took into consideration the most conserved 
amino acids found in the motif. In addition, in translation of the Walker A into nucleotide sequence 
we followed two different procedures, considering codon usages of the organisms. In the first 
approach, we considered the gram negative codon usage and prepared primer ABC1 according to 
this. As a second approach the ABC2 primer was constructed according to universal codon usage. 
Finally, similar to the ABC2 the primer ABC3 was designed by using universal codon usage, but in 
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this case the primer had degeneracy in some bases. The reason for designing of these primers was to 
include all the possibilities to get a significant band at the end of the PCR assays.  In these 
experiments, the primers, ABC1, ABC2, ABC3 were used as forward primers and primer B5-2 was 
used as reverse primer. At the end of optimization of the PCR, we obtained two significant bands, 
ABC1a and ABC1b, 750bp and 1000bp in length respectively. These bands were significant because 
- based on the predicted length of our ATPase domain - the expected length of the PCR product 
ranged from 700 bp to 1000 bp. According to this, the bands obtained were promising that they 
could include the Walker A motif. After isolation of these PCR products from the agarose gel, we 
directly sequenced the PCR products. However, the direct sequencing of these PCR products did not 
give a satisfactory result. Then, we made TA cloning of the PCR products and sequenced the inserts. 
Unfortunately the restriction enzyme analysis, done after isolation of the plasmid, showed that TA 
cloning was not executed successfully. 
 
Future perspectives 
 
As a future study we will continue to do the sequencing of all clones and complete the 
nucleotide sequence of these clones. Moreover, we will perform TA cloning and subsequent 
sequencing reaction of the PCR products. 
In order to go to 5’ end of the nucleotide sequence, another thing that could be done in 
future studies is RACE (Rapid Amplification of cDNA Ends). Moreover, the PCR assays could 
be continued till the Walker A region obtained. After obtaining the complete nucleotide 
sequence of this ATPase domain, experiments to find its function could be performed. 
However, since mostly the domains of the ABC type transporters of bacteria were located in 
different parts of the genome (Schmitt L 2002) prior to the experiments, a careful search of 
which procedures will be followed should be done.  
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